Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
UBS
Teva
Fish and Richardson
Julphar
Chinese Patent Office
Colorcon
Cerilliant
Dow

Generated: August 17, 2017

DrugPatentWatch Database Preview

Alcon Company Profile

« Back to Dashboard

What is the competitive landscape for ALCON, and when can generic versions of ALCON drugs launch?

ALCON has forty-six approved drugs.

There is one US patent protecting ALCON drugs. There is one tentative approval on ALCON drugs.

There are eighteen patent family members on ALCON drugs in sixteen countries.

Summary for Applicant: Alcon

Patents:1
Tradenames:42
Ingredients:36
NDAs:46
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon
CHLORAMPHENICOL
chloramphenicol
SOLUTION/DROPS;OPHTHALMIC062628-001Sep 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
STATROL
neomycin sulfate; polymyxin b sulfate
SOLUTION/DROPS;OPHTHALMIC050456-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
ISOPTO CETAMIDE
sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC080020-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
ECONOPRED
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC017468-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
PROFENAL
suprofen
SOLUTION/DROPS;OPHTHALMIC019387-001Dec 23, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Alcon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon
BETOPTIC
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019270-001Aug 30, 1985► Subscribe► Subscribe
Alcon Pharms Ltd
NAVSTEL
calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate
SOLUTION;IRRIGATION022193-001Jul 24, 2008► Subscribe► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001► Subscribe► Subscribe
Alcon
BETOPTIC PILO
betaxolol hydrochloride; pilocarpine hydrochloride
SUSPENSION/DROPS;OPHTHALMIC020619-001Apr 17, 1997► Subscribe► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ALCON drugs

Drugname Dosage Strength Tradename Submissiondate
travoprost
Ophthalmic Solution0.00%
TRAVATAN
11/28/2008
ketotifen fumarate
Ophthalmic Solution0.03%
ZADITOR
12/23/2004

International Patent Family for Alcon Drugs

Country Document Number Estimated Expiration
Denmark1343474► Subscribe
Portugal1343474► Subscribe
TaiwanI290050► Subscribe
Austria459337► Subscribe
Australia3960102► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Alcon Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012017,C1920764Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
C/GB08/018United Kingdom► SubscribePRODUCT NAME: FOSAMPRENAVIR CALCIUM: ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2(PHOSPHONOOXY)PROPYL)-CARBABAMIC ACID C-((3S)-TETRAHYDRO-3-FURANYL) ESTER CALCIUM SALT; REGISTERED: UK EU/1/04/282/001 20040712; UK EU/1/04/282/002 20040712
1920764/01Switzerland► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
0722Netherlands► SubscribePRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Army
Julphar
UBS
Teva
Cerilliant
Boehringer Ingelheim
Express Scripts
McKinsey
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot